Asymmetric Synthesis with Organofluorines and Terminal Ynamides
Asymmetric Synthesis with Organofluorines and Terminal Ynamides
批准号:
9441070
负责人:
Christian Wolf
金额:
$42.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-10 至 2020-09-14
关键词:
AcidityAgrochemicalsAlkaloidsAlkenesAlkynesAttentionBiologicalBiological AvailabilityCarbonCatalysisChemicalsChemistryComplementComplexDevelopmentDimerizationEducational StatusEflornithineElectronsExhibitsFluoridesFluorineFutureFuture GenerationsGenerationsGoalsHealth SciencesHealthcare IndustryHigh School StudentIodidesIsatinLaboratoriesLeadLigandsMetabolicMetalsMethodologyMethodsMotivationNatural ProductsOutcomePathway interactionsPatternPharmaceutical PreparationsPharmacologic SubstancePharmacologyPlanet EarthPrevalenceProcessProductionPropertyProtocols documentationReactionResearchResistanceRoleRouteScientistTimeUrsidae FamilyWorkbasec newcatalystchemical synthesisdeprotonationdimerdrug marketenolatefunctional groupgraduate studentimprovedinfancyinsightinterestlipophilicityneglectnovelnucleophilic additionnucleophilic substitutionoxetanescaffoldscreeningstemsuccesstoolundergraduate student
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The ever-increasing demand for chiral compounds and the impressive
prevalence of fluorinated pharmaceuticals on the US drug market generate compelling
motivation for the development of synthetic methods that yield practical access to
multifunctional organofluorines. The introduction of strategies that provide control over
the unique stability and reactivity patterns of fluorinated species offers invaluable
opportunities to streamline chemical synthesis of current and future drugs. The versatile
chemistry of terminal ynamides which have been barely investigated to date and new C-
F functionalization methodology recently discovered in our lab bear similar promise.
The goals of the proposed research are to introduce asymmetric methods for
catalytic carbon-carbon bond formation with fluorinated nucleophiles generated either by
mild deacylative C-C cleavage of readily available precursors or from multifunctional
prenucleophiles, to continue our spearheading efforts with asymmetric ynamide addition
reactions, and to develop new C-F functionalization chemistry. The general feasibility of
the planned activities and the synthetic utility prospects are highlighted with ample proof-
of-concept results and mechanistic insights. Considerable emphasis will be placed on
the introduction of currently elusive reactions and new methodologies, for example
unprecedented asymmetric Michael addition/Nef reactions, C-F activation for selective
carbon-carbon and carbon-heteroatom bond formation, and base-free ynamide
additions. In addition, the overall usefulness of the proposed multifunctional chiral
building blocks for the total synthesis of biologically active compounds will be explored.
The reaction development efforts will be guided by detailed mechanistic studies and
include screening and systematic optimization of a variety of organocatalysts and chiral
ligands, including bisoxazolidines which have been developed previously in our
laboratory. Altogether, the anticipated outcomes of this proposal are likely to afford new
tools and directions for asymmetric catalysis with organofluorines and terminal ynamides
as well as general reaction insights and synthetic opportunities that will be of interest to
a wide range of synthetic and medicinal chemists.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Asymmetric Catalysis and Selective C-F Bond Functionalization with Organofluorines
-
批准号:10729601
-
项目类别:
-
资助金额:$45.87万
-
财政年份:2013
-
负责人:Christian Wolf
-
依托单位:
Synthesis of Chiral Organofluorines via Catalytic Asymmetric C-C Bond Formation w
-
批准号:8495556
-
项目类别:
-
资助金额:$33.73万
-
财政年份:2013
-
负责人:Christian Wolf
-
依托单位:
Designing HTA therapy for drug resistant malaria
-
批准号:7387397
-
项目类别:
-
资助金额:$36.09万
-
财政年份:2005
-
负责人:Christian Wolf
-
依托单位:
Designing HTA therapy for drug resistant malaria
-
批准号:7591780
-
项目类别:
-
资助金额:$36.09万
-
财政年份:2005
-
负责人:Christian Wolf
-
依托单位:
Designing HTA therapy for drug resistant malaria
-
批准号:7022987
-
项目类别:
-
资助金额:$37.89万
-
财政年份:2005
-
负责人:Christian Wolf
-
依托单位:
Designing HTA therapy for drug resistant malaria
-
批准号:7196435
-
项目类别:
-
资助金额:$36.79万
-
财政年份:2005
-
负责人:Christian Wolf
-
依托单位:
Designing HTA therapy for drug resistant malaria
-
批准号:6920094
-
项目类别:
-
资助金额:$38.8万
-
财政年份:2005
-
负责人:Christian Wolf
-
依托单位:
海外基金